CommercialCoverageMedium impact
08.00.13am, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
Independence Blue Cross·Allergy & Immunology, Hematology, Oncology +3 more·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Policy 08.00.13am regarding Immune Globulin Intravenous (IVIG) and Subcutaneous (SCIG) has been updated with changes to coverage positions, medical coding, and general guidelines. This affects billing and reimbursement for immunoglobulin treatments commonly used for immune deficiency disorders and other conditions.
Action Required
Before January 1, 2026: Billing team must review updated IVIG/SCIG policy requirements and update billing procedures accordingly. Monitor for specific coding and coverage changes when full policy details become available. Ensure documentation meets new guidelines for immunoglobulin treatments.